According to the results from the Kaplan–Meier plotter, Figure 3a suggested that enhanced expression of NOL7 was associated with poor overall survival (OS) in ESCA (p < 0.05), KIRP (p < 0.001), LIHC (p < 0.01), sarcoma (SARC) (p < 0.001), and UCEC (p < 0.05). The gene discussed is NOL7; the disease is sarcoma.